Consensus Align Technology, Inc.

Stocks

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 05/09/2026 am IST			5-day change	1st Jan Change
158.64 ^USD	-0.76%		+0.67%	+1.59%

03/09	STAAR Surgical Appoints Ben Park as Chief Technology Officer	MT
01/09	Align Technology, Inc. Announces Board Changes	CI

Evolution of the Average Target: Align Technology, Inc.

Evolution of the Target Price: Align Technology, Inc.

Changes in Analyst Recommendations: Align Technology, Inc.

0b90e8f6154a68928adb413.1veN-zanLpeM5MY-C6vLV0rQaolejBhmxLZ3Y71kHgY.u7y7uUGeTOC4trBHcuO7MgKCMLxvw2hegtMdFt4tREuaxvqfZNdlusKM9g~e2e0a5be5f559da82fdf855426fed677

Analysts' recommendations: Align Technology, Inc.

23/07	UBS Adjusts Price Target on Align Technology to $189 From $186, Maintains Neutral Rating	MT
20/07	Leerink Partners Adjusts Price Target on Align Technology to $235 From $230, Maintains Outperform Rating	MT
09/07	BMO Capital Initiates Align Technology at Outperform With $209 Price Target	MT
30/04	Leerink Partners Adjusts Align Technology Price Target to $230 From $225	MT
30/04	Evercore ISI Adjusts Align Technology Price Target to $220 From $200	MT
24/04	Morgan Stanley Adjusts Price Target on Align Technology to $188 From $169, Maintains Equalweight Rating	MT
21/04	Piper Sandler Lifts Price Target on Align Technology to $235 From $220, Maintains Overweight Rating	MT
15/04	Citigroup Initiates Align Technology at Buy With $240 Price Target	MT
18/03	Align Technology Shares Rise After Barclays Upgrade	MT
17/03	Analyst recommendations: Align Technology, Eli Lilly, Adobe, Salesforce…
17/03	Barclays Upgrades Align Technology to Overweight From Equalweight, Price Target is $200	MT
10/02	Align Technology Shares Rise After HSBC Upgrade	MT
09/02	Analyst recommendations: Align, Take-Two, Biogen, PayPal, Stellantis…
09/02	HSBC Upgrades Align Technology to Buy From Hold, Adjusts Price Target to $200 From $150	MT
05/02	UBS Adjusts Price Target on Align Technology to $185 From $175, Maintains Neutral Rating	MT
05/02	Baird Adjusts Price Target on Align Technology to $218 From $205, Maintains Outperform Rating	MT
05/02	Evercore ISI Adjusts Price Target on Align Technology to $200 From $180, Maintains Outperform Rating	MT
05/02	Jefferies & Co Adjusts Align Technology Price Target to $185 From $155, Maintains Hold Rating	MT
05/02	Stifel Nicolaus Adjusts Align Technology PT to $210 From $200, Maintains Buy Rating	MT
05/02	Wells Fargo Adjusts Align Technology PT to $200 From $181, Maintains Overweight Rating	MT
05/02	Piper Sandler Adjusts Align Technology PT to $220 From $200, Maintains Overweight Rating	MT
05/02	Leerink Partners Adjusts Align Technology PT to $225 From $210, Maintains Outperform Rating	MT
05/02	Mizuho Adjusts Price Target on Align Technology to $215 From $200, Maintains Outperform Rating	MT
05/02	Morgan Stanley Raises Price Target on Align Technology to $169 From $154, Keeps Equalweight Rating	MT
22/01	Leerink Partners Adjusts Align Technology Price Target to $210 From $189, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALIGN TECHNOLOGY, INC.					+31.5%
	ABBOTT LABORATORIES					+10.96%
	MEDTRONIC PLC					+11.25%
	CENCORA, INC.					+11.59%
	HOYA CORPORATION					+27.04%
	BECTON, DICKINSON AND COMPANY					+5.91%
	DEXCOM, INC.					+7.08%
	MEDLINE INC.					+21.89%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.05%
	TERUMO CORPORATION					+29.14%
	Average					+17.54%
	Weighted average by Cap.					+13.84%